Morphine induces apoptosis of human microglia and neurons

Shuxian Hu1, Wen S Sheng, James R Lokensgard

  • 1Neuroimmunology Laboratory, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA.

Neuropharmacology
|May 17, 2002
PubMed

Insights

Morphine induces apoptosis in human fetal microglia and neurons, but not astrocytes. This opiate-induced cell death involves caspase-3 and suggests potential risks to fetal brain development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Apoptosis is crucial for brain development and neurodegenerative diseases.
  • Opiates are known to induce cell death in immune and nervous system cells.

Purpose of the Study:

  • To investigate the effect of morphine on apoptosis in primary human fetal microglial, astrocyte, and neuronal cell cultures.
  • To elucidate the mechanisms underlying morphine-induced apoptosis.

Main Methods:

  • Primary human fetal microglial, astrocyte, and neuronal cell cultures were exposed to morphine.
  • Apoptosis was assessed, and involvement of opiate receptors and caspase-3 was investigated using naloxone and a caspase-3 inhibitor.
  • Confocal microscopy was used to visualize active caspase-3 and DNA fragmentation.

Main Results:

  • Morphine (10(-6) M) significantly increased apoptosis in microglia and neurons (approx. fourfold increase).
  • Astrocytes were resistant to morphine-induced apoptosis.
  • Neurons were more sensitive to morphine's apoptotic effects than microglia.
  • Naloxone blocked morphine-induced apoptosis, indicating opiate receptor involvement.
  • Caspase-3 inhibition and co-localization of active caspase-3 with DNA fragmentation confirmed caspase-3's role in the execution phase.

Conclusions:

  • Morphine induces apoptosis in human fetal microglia and neurons via an opiate receptor-mediated pathway involving caspase-3.
  • Astrocytes are resistant to morphine-induced apoptosis.
  • These findings highlight potential risks of opiate exposure to fetal brain development and neurodegenerative disease progression.